Cardiovascular Disease
In diabetic adults in the U.S., aspirin use is increasing
Published in Medical Letter on the CDC and FDA, April 2nd, 2006
"The role of aspirin in prevention of cardiovascular disease (CVD) and cardiovascular complications among people with diabetes has been examined. A Healthy People 2010 objective calls for increasing the proportion of people with diabetes aged {{>=}}40 years who take aspirin {{>=}}15 times per month. Data from 2003 Behavioral Risk Factor Surveillance System were used to examine: the prevalence of aspirin intake; aspirin use among those with CVD; aspirin use among those with diabetes; current status with respect to Healthy People objective 5-16; and changes in aspirin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Generic Drugs
U.S. FDA approves first generic version of Flonase - Obesity Epidemiology
Body mass index of healthy men is compared with healthy women in U.S. - Proteomics
Hemorrhagic fever virus glycoprotein precursor cleaves to generate new glycoprotein - Virology
Wild-type hepatitis A virus has been stably grown in cell culture - Alzheimer Disease
U.S. NIH report on controlling cardiovascular risk, enhancing cognitive function published - Amebiasis Vaccine
Amebiasis vaccine progress is reviewed - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
